Mazdutide (Myotrope) – Dual GLP-1 Glucagon Peptide for Laboratory Research

Myotrope 's Mazdutide is a groundbreaking peptide that functions as a dual GLP-1 and glucagon receptor agonist . In laboratory studies, Mazdutide is used to study metabolic processes, fat burning, weight loss, and regenerative effects . By simultaneously activating the GLP-1 and glucagon pathways, the peptide allows researchers to measure glucose control, energy expenditure, and tissue repair in preclinical models.

How does Mazdutide work?

Mazdutide is a synthetic analog of the natural hormone oxyntomodulin (OXM). In preclinical studies, it activates both the GLP-1 receptor (GLP-1R) and the glucagon receptor (GCGR) .

• GLP-1R activation: promotes glucose-dependent insulin secretion, inhibits glucagon production, delays gastric emptying, and increases satiety.
• GCGR activation: stimulates energy expenditure, promotes liver lipolysis and reduces visceral fat.
• The combined effect in laboratory models supports weight gain prevention, fat breakdown and metabolic regulation .

All observations are based on preclinical and laboratory research , never human application.

Benefits of Mazdutide

• Supports research into weight loss and fat burning
• Stimulates metabolic balance and glucose control in laboratory models
• Promotes energy expenditure and liver fat breakdown via glucagon receptor activation
• Supports studies on tissue repair and regenerative processes
• Ideal for synergistic studies with other peptides such as BPC‑157
• Buying from Myotrope guarantees research-grade purity and COA
• Suitable for anti-aging, skin rejuvenation and muscle preservation in laboratory research

Legal disclaimer

Mazdutide is intended for laboratory research only. It is not approved for human consumption, diagnosis, treatment, or prevention of disease. All information is based on preclinical and laboratory research , not on human use.